JP2023527396A5 - - Google Patents
Info
- Publication number
- JP2023527396A5 JP2023527396A5 JP2022572736A JP2022572736A JP2023527396A5 JP 2023527396 A5 JP2023527396 A5 JP 2023527396A5 JP 2022572736 A JP2022572736 A JP 2022572736A JP 2022572736 A JP2022572736 A JP 2022572736A JP 2023527396 A5 JP2023527396 A5 JP 2023527396A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030968P | 2020-05-28 | 2020-05-28 | |
| US63/030,968 | 2020-05-28 | ||
| PCT/US2021/034454 WO2021242982A1 (en) | 2020-05-28 | 2021-05-27 | Galectin-3 inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023527396A JP2023527396A (ja) | 2023-06-28 |
| JP2023527396A5 true JP2023527396A5 (https=) | 2024-06-03 |
| JPWO2021242982A5 JPWO2021242982A5 (https=) | 2024-06-03 |
| JP7772718B2 JP7772718B2 (ja) | 2025-11-18 |
Family
ID=76502884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572736A Active JP7772718B2 (ja) | 2020-05-28 | 2021-05-27 | ガレクチン－３阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12291522B2 (https=) |
| EP (1) | EP4157833A1 (https=) |
| JP (1) | JP7772718B2 (https=) |
| KR (1) | KR20230018431A (https=) |
| CN (1) | CN115768768A (https=) |
| WO (1) | WO2021242982A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026002250A1 (zh) * | 2024-06-28 | 2026-01-02 | 上海济煜医药科技股份有限公司 | 四唑基取代的吡喃半乳糖苷衍生物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| US8828971B2 (en) | 2012-10-10 | 2014-09-09 | Galectin Therapeutics, Inc. | Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
| JP2015535233A (ja) | 2012-10-31 | 2015-12-10 | ガレクト・バイオテック・エイビイ | ガレクチン−３のガラクトシド阻害剤及び肺線維症のためのその使用 |
| JP6904906B2 (ja) | 2015-01-30 | 2021-07-21 | ガレクト・バイオテック・エイビイ | ガレクチンの新規なガラクトシド阻害剤 |
| ES2921500T3 (es) | 2015-11-09 | 2022-08-26 | Galecto Biotech Ab | 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas |
| MX2019007646A (es) * | 2016-12-23 | 2019-09-06 | Arvinas Operations Inc | Moleculas quimericas dirigidas a la proteolisis del egfr y metodos asociados de uso. |
| CA3062648A1 (en) | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the prevention and treatment of diseases and the use thereof |
| EP3652329B1 (en) * | 2017-07-12 | 2023-10-04 | Dana-Farber Cancer Institute, Inc. | Compounds for tau protein degradation |
| WO2019067702A1 (en) * | 2017-09-27 | 2019-04-04 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| WO2019075045A1 (en) | 2017-10-11 | 2019-04-18 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| CA3092677A1 (en) * | 2018-03-06 | 2019-09-12 | Icahn School Of Medicine At Mount Sinai | Serine threonine kinase (akt) degradation / disruption compounds and methods of use |
| JP7190513B2 (ja) | 2018-06-15 | 2022-12-15 | ブリストル－マイヤーズ スクイブ カンパニー | ガレクチン－３抑制剤を模したテトラヒドロピラン系チオ二糖類 |
| MX2021001957A (es) * | 2018-08-22 | 2021-07-15 | Cullgen Shanghai Inc | Compuestos de degradacion y metodos de uso del receptor de tropomiosina quinasa (trk). |
-
2021
- 2021-05-27 EP EP21733338.4A patent/EP4157833A1/en active Pending
- 2021-05-27 KR KR1020227045460A patent/KR20230018431A/ko active Pending
- 2021-05-27 CN CN202180038169.4A patent/CN115768768A/zh active Pending
- 2021-05-27 US US17/927,426 patent/US12291522B2/en active Active
- 2021-05-27 WO PCT/US2021/034454 patent/WO2021242982A1/en not_active Ceased
- 2021-05-27 JP JP2022572736A patent/JP7772718B2/ja active Active